203 related articles for article (PubMed ID: 19237390)
1. Adverse effects of salmeterol in asthma: a neuronal perspective.
Lommatzsch M; Lindner Y; Edner A; Bratke K; Kuepper M; Virchow JC
Thorax; 2009 Sep; 64(9):763-9. PubMed ID: 19237390
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
3. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
5. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
Lipworth BJ
Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
7. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
8. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
[TBL] [Abstract][Full Text] [Related]
9. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
Kuna P
Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
11. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
Kimura T; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone propionate/salmeterol combination.
Lipworth BJ
J Allergy Clin Immunol; 2001 Apr; 107(4):746. PubMed ID: 11295673
[No Abstract] [Full Text] [Related]
14. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
15. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A
Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609
[TBL] [Abstract][Full Text] [Related]
16. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.
Lötvall J; Svedmyr N
Lung; 1993; 171(5):249-64. PubMed ID: 8105155
[TBL] [Abstract][Full Text] [Related]
18. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Lung; 2006; 184(4):217-22. PubMed ID: 17006748
[TBL] [Abstract][Full Text] [Related]
19. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
Rabinovitch N; Mauger DT; Reisdorph N; Covar R; Malka J; Lemanske RF; Morgan WJ; Guilbert TW; Zeiger RS; Bacharier LB; Szefler SJ
J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of salmeterol and fluticasone or theophylline in COPD.
Cazzola M; Di Lorenzo G; Di Perna F; Calderaro F; Testi R; Centanni S
Chest; 2000 Dec; 118(6):1576-81. PubMed ID: 11115442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
